Loading clinical trials...

Efficacy and Safety Phase III Clinical Study of VC005 Tablets in Subjects With Active Ankylosing Spondylitis. | Clinical Trials | Clareo Health

Back to clinical trial search

RECRUITINGPhase 3NCT07172360

Efficacy and Safety Phase III Clinical Study of VC005 Tablets in Subjects With Active Ankylosing Spondylitis.

This clinical trial is a multicenter, randomized, double-blind, controlled phase III clinical study.

Lead sponsor: Jiangsu vcare pharmaceutical technology co., LTD•1 locations•View source on ClinicalTrials.gov

Clareo plain-language summary

What this study is about

Generating AI summary...

Clareo turns complex medical information into clear understanding you can use.

Bring this clarity to your next appointment.

Keep all your medical notes and next steps in one place.

Contacts

xiaojuan lai

CONTACT

15358160458 lai_xiaojuan@vcarepharmatech.com

Related studies

COMPLETEDPhase 2

Efficacy and Safety Clinical Study of VC005 Tablets in Subjects With Active Ankylosing Spondylitis.

NCT05814939 · Active Ankylosing Spondylitis

COMPLETEDPhase 3

Study to Test the Safe and Effective Use of an e-Device for the Self-injection of Certolizumab Pegol Solution by Subjects With Moderate to Severe Active Rheumatoid Arthritis, Active Ankylosing Spondylitis, Active Psoriatic Arthritis, or Moderately to Severely Active Crohn's Disease

NCT03357471 · Moderate and Severe Active Rheumatoid Arthritis, Active Psoriatic Arthritis, and more

Data from ClinicalTrials.govLast updated on ClinicalTrials.gov: January 2, 2026Terms

Trial snapshot

StatusRECRUITING

PhasePHASE3

Enrollment420

Start dateDec 2025

Last updatedJan 2, 2026

Condition

Active Ankylosing Spondylitis

Locations shown

Peking University People's Hospital

Beijing, Beijing Municipality

For caregivers

Use Clareo to keep notes, questions, trial details, and next steps organized before and after appointments.

Data Source & Attribution

This clinical trial information is sourced from ClinicalTrials.gov, a service of the U.S. National Institutes of Health.

ClinicalTrials.gov last update: January 2, 2026Data synced to Clareo: May 3, 2026

Modifications: This data has been reformatted for display purposes. Eligibility criteria have been parsed into inclusion/exclusion sections. Location data has been geocoded to enable distance-based search. For the authoritative and most current information, please visit ClinicalTrials.gov.

Neither the United States Government nor Clareo Health make any warranties regarding the data. Check ClinicalTrials.gov frequently for updates.

View ClinicalTrials.gov Terms and Conditions